Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Olema Pharmaceuticals (OLMA) Other Non Operating Income (2020 - 2026)

Olema Pharmaceuticals (OLMA) has 7 years of Other Non Operating Income data on record, last reported at $121000.0 in Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 402.5% to $121000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $184000.0, a 308.89% increase, with the full-year FY2025 number at $23000.0, down 77.45% from a year prior.
  • Other Non Operating Income reached $121000.0 in Q1 2026 per OLMA's latest filing, up from $13000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for OLMA hit a ceiling of $138000.0 in Q3 2024 and a floor of -$120000.0 in Q3 2022.
  • A 5-year average of $11764.7 and a median of $13000.0 in 2025 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: skyrocketed 2100.0% in 2022, then crashed 335.29% in 2025.
  • Tracing OLMA's Other Non Operating Income over 5 years: stood at $67000.0 in 2022, then skyrocketed by 38.81% to $93000.0 in 2023, then tumbled by 200.0% to -$93000.0 in 2024, then surged by 113.98% to $13000.0 in 2025, then surged by 830.77% to $121000.0 in 2026.
  • Business Quant data shows Other Non Operating Income for OLMA at $121000.0 in Q1 2026, $13000.0 in Q4 2025, and $12000.0 in Q3 2025.